Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock-Reference-Cited by-同舟云学术

Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock

Published:2021-03 Issue: Volume:213 Page:113057
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Dreas Agnieszka^ORCID,Kucwaj-Brysz Katarzyna,Pyziak Karolina^ORCID,Kulesza Urszula,Wincza Ewelina,Fabritius Charles-Henry,Michalik Kinga^ORCID,Gabor-Worwa Ewelina,Gołas Aniela,Milik Mariusz,Masiejczyk Magdalena,Majewska Eliza,Pyśniak Kazimiera,Wójcik-Trechcińska Urszula,Sandowska-Markiewicz Zuzanna,Brzózka Krzysztof,Ostrowski Jerzy,Rzymski Tomasz,Mikula Michal^ORCID

Funder

Narodowe Centrum Badań i Rozwoju

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference46 articles.

1. Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for cancer therapy: recent progress in the development of MNK inhibitors;Dreas;Curr. Med. Chem.,2017

2. Mnk kinase pathway: cellular functions and biological outcomes;Joshi;World J. Biol. Chem.,2014

3. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma;Zhan;J. Clin. Invest.,2017

4. Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia;Kosciuczuk;Cytokine,2017

5. Signalling to eIF4E in cancer;Siddiqui;Biochem. Soc. Trans.,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels;Scientific Reports;2024-02-20

2. MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation;European Journal of Medicinal Chemistry;2023-11

3. Oncology Drug Repurposing for Sepsis Treatment;Biomedicines;2022-04-17

4. Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors;Bioorganic & Medicinal Chemistry;2021-11

5. Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models;International Journal of Molecular Sciences;2021-09-22